George Sharbeen, Co-Lead Pancreatic Cancer Translational Research Group at UNSW Sydney, shared a post on LinkedIn:
“I’m pleased to share our new article published in Oncogene which details the therapeutic potential of targeting HSP47 in both pancreatic cancer cells and cancer-associated fibroblasts. Our study also identifies an interesting link between HSP47 expression in the tumour cell compartment of pancreatic cancer and overall survival in patients.
A big thank you to our multidisciplinary team of co-authors and the generous support of our funders that made this study possible.”
Title: HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer
Authors: George Sharbeen, Estrella Gonzales-Aloy, Janet Youkhana, John Kokkinos, Rosa Mistica C. Ignacio, Joshua A. McCarroll, Aparna S. Raina, Chantal Kopecky, Jie Liu, Amanda Mawson, Andrea Nunez, Cyrille Boyer, Mert Erkan, David Goldstein, Koroush S. Haghighi, Paul Timpson, Sean C. Warren, Kendelle J. Murphy, Anthony J. Gill, Amber L. Johns, Angela Chou, Elvis Pandzic, Sandra Fok, Renee Whan, Val Gebski, Jennifer P. Morton, Minoti Apte, Phoebe A. Phillips.
Other articles on OncoDaily.